Antiretroviral therapy coverage in Azerbaijan
Azerbaijan: Antiretroviral therapy coverage was 86.0% in 2024. ◆ Volatile
Antiretroviral therapy coverage in Azerbaijan, 2000–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of people living with HIV.
Analysis
Azerbaijan recorded 86.0% for antiretroviral therapy coverage in 2024. That is the highest value across all 24 years on record.
That represents a change of up 13.2% on the previous year and up 309.5% over ten years.
Over the whole period, antiretroviral therapy coverage in Azerbaijan peaked at 86.0% in 2024 and was at its lowest, 0.0%, in 2000.
That places Azerbaijan 33rd out of 143 countries with data for 2024, putting it in the top quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Antiretroviral therapy coverage in Azerbaijan, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2006 | 0.0% | — |
| 2007 | 1.0% | — |
| 2008 | 2.0% | +100.0% |
| 2009 | 3.0% | +50.0% |
| 2010 | 6.0% | +100.0% |
| 2011 | 9.0% | +50.0% |
| 2012 | 11.0% | +22.2% |
| 2013 | 15.0% | +36.4% |
| 2014 | 21.0% | +40.0% |
| 2015 | 27.0% | +28.6% |
| 2016 | 33.0% | +22.2% |
| 2017 | 39.0% | +18.2% |
| 2018 | 46.0% | +17.9% |
| 2019 | 56.0% | +21.7% |
| 2020 | 60.0% | +7.1% |
| 2021 | 66.0% | +10.0% |
| 2022 | 67.0% | +1.5% |
| 2023 | 76.0% | +13.4% |
| 2024 | 86.0% | +13.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.7% | 0.0% | 3.0% | 9 |
| 2010s | 26.3% | 6.0% | 56.0% | 10 |
| 2020s | 71.0% | 60.0% | 86.0% | 5 |
Countries ranked near Azerbaijan
More health data for Azerbaijan
- Un projection of annual infant deaths, annual growth rate -1.12 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.1127 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,241 deaths per 1,000 people (2090)
- Number of infants who die before age 1 264 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -3.72 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0286 units per person (2025)
- Population ages 00-04, male, annual growth rate -4.06 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is antiretroviral therapy coverage in Azerbaijan?
- Antiretroviral therapy coverage in Azerbaijan was 86.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage recorded in Azerbaijan?
- The highest recorded value was 86.0% in 2024.
- What is the lowest antiretroviral therapy coverage recorded in Azerbaijan?
- The lowest recorded value was 0.0% in 2000.
- How does Azerbaijan rank for antiretroviral therapy coverage?
- Azerbaijan ranks 33rd out of 143 countries with data for 2024.
- Is antiretroviral therapy coverage rising or falling in Azerbaijan?
- Over the last ten years it is up 309.5%. The long-run trend across the full record is volatile.
- Where does this Azerbaijan data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage (% of people living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 24 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.